NANOG and lip and oral cavity carcinoma: In addition, patients harboring NANOG–positive dysplasias either considering cytoplasmic or nuclear NANOG expression were consistently and significantly associated with an increased risk of progression to oral cancer (p = 0.02 and p = 0.04, respectively) (Table 2).